DexCom Announces Upcoming Conference Presentations

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences:

• Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the Raymond James & Associates’ 38th Annual Institutional Investors Conference in Orlando, Florida on Monday, March 6, 2017 at 4:00pm (EST). The presentation, which will occur live at the JW Marriott Grande Lakes Hotel, will be concurrently webcast.
• Matthew Dolan, Senior Director Corporate Affairs, will present an update on the company at the Cowen and Company 37th Annual Health Care Conference in Boston, Massachusetts on Tuesday, March 7, 2017 at 8:00am (EST). The presentation, which will occur live at the Boston Marriott Copley Place, will be concurrently webcast.
• Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the Barclays Global Healthcare Conference in Miami Beach, Florida on Thursday, March 16, 2017 at 8:30am (EDT). The presentation, which will occur live at the Loews Miami Beach Hotel, will be concurrently webcast.
• Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the Oppenheimer 27th Annual Healthcare Conference in New York City, New York on Tuesday, March 21, 2017 at 1:00pm (EDT). The presentation, which will occur live at the Westin New York Grand Central Hotel, will be concurrently webcast.

The link to each webcast will be available on the DexCom website at www.dexcom.com by navigating to “Our Company,” then “Investor Relations,” and finally “Events and Webcasts” and will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170222006255/en/

DexCom, Inc.Steven R. PacelliExecutive Vice President, Strategy and Corporate Development(858) 200-0200